Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2517 -0.1227%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: Tokyo
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Takeda Pharmaceutical Co Ltd

Add to Portfolio

4502:JP

3,300 JPY 75 2.33%

As of 02:00:00 ET on 05/25/2012.

Company Profile for Takeda Pharmaceutical Co Ltd (4502)

Takeda Pharmaceutical Company Limited mainly manufactures and sells pharmaceuticals, food supplements, and chemical products like polyurethane. The Company also produces food, agrochemicals, and environment-related products such as pollution detectors. Takeda Pharmaceutical researches, develops, and promotes the products through its related companies in the US, Europe, and Asia.

Contact Information

Takeda Pharmaceutical Co Ltd

4-1-1 Dosho-machi
Chuo-ku Osaka City
Osaka, 540-8645
Japan
Phone: 81-6-6204-2111
Fax: 81-6-6204-2035

Key Executives for Takeda Pharmaceutical Co Ltd (4502)

Yasuchika HasegawaPresidentToyoji YoshidaCAO/Managing Director
Shigenori OhkawaChief Scientific Ofcr/DirectorYasuhiko YamanakaManaging Director
Frank MorichDirectorTadataka Yamada "Tachi"Director

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement